Yao et al. reported that inhibition of CDK9 disrupts the SIRT1-FOXO3-BNIP3 axis and the PINK1-PRKN pathway, effectively blocking mitophagy initiation in HCC (Yao et al., 2022). This evidence concerns the gene PRKN and hepatocellular carcinoma.